NCT00655655 2024-08-21Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsMayo ClinicPhase 1 Completed96 enrolled
NCT00227773 2015-10-08Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Withdrawn